Back
Vaxcyte Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
75
PCVX
Vaxcyte
Last Price:
74.60
Seasonality Move:
14.24%
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
41.30
Seasonality Move:
9.35%
Buy
75
Vaxcyte (PCVX)
is a Buy
Is Vaxcyte a Buy, Sell or Hold?
- The current Vaxcyte [PCVX] share price is $74.57. The Score for PCVX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- PCVX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $41.31. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PCVX Stock Price Chart
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $41.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
PCVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.07 | Buy |
| Relative Strength Index (14 RSI): | 72.34 | Buy |
| Chaikin Money Flow: | -239476 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.34 - 68.8) | Buy |
| Bollinger Bands (100): | (61.94 - 72.68) | Buy |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.04 | Sell |
| Relative Strength Index (14 RSI): | 34.23 | Sell |
| Chaikin Money Flow: | -659109 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.82 - 49.38) | Sell |
| Bollinger Bands (100): | (49.98 - 66.92) | Sell |
PCVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.03 | Buy |
| 20-day SMA: | 65.28 | Buy |
| 50-day SMA: | 65.85 | Buy |
| 200-day SMA: | 59.04 | Buy |
| 8-day EMA: | 70.18 | Buy |
| 20-day EMA: | 67.12 | Buy |
| 50-day EMA: | 66.25 | Buy |
| 200-day EMA: | 60.23 | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.04 | Sell |
| 20-day SMA: | 45.31 | Sell |
| 50-day SMA: | 51.48 | Sell |
| 200-day SMA: | 51.74 | Sell |
| 8-day EMA: | 42.54 | Sell |
| 20-day EMA: | 45.19 | Sell |
| 50-day EMA: | 50.4 | Sell |
| 200-day EMA: | 55.58 | Sell |
Vaxcyte Earnings Growth & PCVX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.88 per share, and an increase next year of $0.04 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.34 per share, an increase this year of $3.60 per share, and an increase next year of $2.16 per share.
Vaxcyte Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||